Trademark Search in Canada

PHARSQ

View On IC.GC.CA

REGISTERED

on 5 Jun 2024

Last Applicant/ Owned by

CHEMISCHE FABRIK BUDENHEIM KG

Rheinstrasse 2755257 Budenheim

Serial Number

1943796 filed on 31^st Jan 2019

Registration Number

TMA1236750 registered on 5^th Jun 2024

Registration expiry Date

5^th Jun 2034

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

1, Place Ville MarieSuite 2500, Montreal

QUEBEC

H3B1R1

PHARSQ

Trademark usage description

chemicals for use in industry, in particular for manufacturing pharmaceuticals; chemicals for use in the pharmaceutical industry, namely, compositions Read More

Classification Information

Class [001]
Chemicals for use in industry, in particular for manufacturing pharmaceuticals; chemicals for use in the pharmaceutical industry, namely, compositions of phosphate salts and/or mixtures thereof used as excipient agents in the manufacture of pharmaceuticals, active chemical ingredients for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of pharmaceuticals; chemical additives for use in the manufacture of medicines

Classification kind code

Class [005]
Chemical preparations for pharmaceutical purposes, namely, inorganic additives, organic additives, active pharmaceutical ingredients and biopharmaceutical additives as part of pharmaceutical compositions for the treatment of (i) infectious diseases, namely, bacteria, virus, mycotic and parasitic infection diseases of the respiratory system, eye, skin, mucous membrane, gastrointestinal system, reproductive organs, central nervous system, (ii) malignant and benign tumors, (iii) diseases of the blood and blood forming organs namely anaemias, coagulation defects, immunodeficiencies, (iv) endocrine diseases and disorders, namely, glucagonoma and growth and thyroid disorders, metabolic diseases and disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome, gout, arthritis, anemia, osteoarthritis, muscular dystrophy, bulimia nervosa, anorexia, hypothyroidism, (v) mental health disorders, (vi) diseases of the central or peripheral nervous system, (vii) diseases of the ear and the back part of the temporal bone, (viii) diseases of the circulatory system, namely acute rheumatic fever, chronic rheumatic heart diseases, hypertensive diseases, ischaemic heart diseases, pulmonary heart disease and diseases of pulmonary circulation, cerebrovascular diseases, diseases of arteries, arterioles and capillaries, diseases of veins, lymphatic vessels and lymph nodes, (ix) diseases of the respiratory system, (x) diseases of the digestive system, (xi) diseases of the musculoskeletal system and connective tissue, namely arthropathies, systemic connective tissue disorders, dorsopathies, soft tissue disorders, osteopathies and chondropathies, (xii) genitourinary disease, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; chemical preparations for use in pharmaceutical preparations, namely, inorganic and organic additives used as a pharmaceutical for medical purposes, namely, medical abortion

Classification kind code

Mark Details

Serial Number

1943796

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 31^st May 2024	Registration Pending
Submitted for opposition 42 on 13^th Mar 2024	Advertised
Submitted for opposition 26 on 14^th Feb 2024	Approved
Submitted for opposition 27 on 14^th Feb 2024	Approval Notice Sent
Submitted for opposition 15 on 23^rd Mar 2023	Correspondence Created
Submitted for opposition 22 on 27^th May 2022	Search Recorded
Submitted for opposition 20 on 27^th May 2022	Examiner's First Report
Submitted for opposition 31 on 6^th Feb 2019	Formalized
Submitted for opposition 1 on 1^st Feb 2019	Created
Submitted for opposition 30 on 31^st Jan 2019	Filed